Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Candel Therapeutics (CADL) Interest Coverage Ratio (2022 - 2025)

Candel Therapeutics' Interest Coverage Ratio history spans 2 years, with the latest figure at 15.33 for Q4 2023.

  • On a quarterly basis, Interest Coverage Ratio fell 9.39% to 15.33 in Q4 2023 year-over-year; TTM through Dec 2023 was 14.79, a 34.72% increase, with the full-year FY2025 number at 22.78, down 42.66% from a year prior.
  • Interest Coverage Ratio hit 15.33 in Q4 2023 for Candel Therapeutics, down from 13.25 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for CADL hit a ceiling of 13.25 in Q3 2023 and a floor of 20.12 in Q2 2022.